SS47 TFA, a cancer immunotherapies[1].
[1]. Jingwen Si, et al. Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies. Cancer Cell.2020 Oct 12;38(4):551-566.e11.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥12,780.00 | 现货 | 1 |
















SS47 TFA, a cancer immunotherapies[1].
[1]. Jingwen Si, et al. Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies. Cancer Cell.2020 Oct 12;38(4):551-566.e11.